99P Sintilimab plus nab-paclitaxel in platinum-refractory head and neck squamous cell carcinoma: A phase II trial. (December 2022) - Zhou, S.; Zuo, L.; Yang, S.; He, X.; Yang, J.; Gui, L.; Li, R.; Yang, Y.